Lynch D H, Miller R E
Department of Immunology, Immunex Corporation, Seattle, WA 98101
Eur J Immunol. 1991 Jun;21(6):1403-10. doi: 10.1002/eji.1830210612.
The draining lymph nodes (LN) of mice injected with viable syngeneic tumor cells contain populations of lymphoid cells which are capable of generating functional cytotoxic T lymphocytes (CTL) during an in vitro culture period without the need of secondary stimulation with irradiated tumor cells or addition of exogenous cytokines. Intravenous injection of as few as 2.5 x 10(6) tumor-reactive effector cells generated using this protocol effectively eliminated challenges of tumor cells at distal skin sites, whereas injection of cultured control lymphoid cells was ineffective at rejecting tumor challenges. The anti-tumor CTL generated from the draining LN of C57BL10 mice immunized with viable syngeneic tumor cells were found to be specific for the tumor used for immunization both in vitro and in vivo. Phenotypic analysis of the cells responsible for tumor elimination (both in vitro. and in vivo) demonstrated the anti-tumor effector cells to be CD4-CD8+ asialo GM1+NK1.1-. Finally, anti-tumor CTL generated during the short in vitro culture period were able to effectively reject pre-existing tumors in vivo in a systemic fashion. These data indicate that the generation of tumor-reactive CTL from the lymphoid cells contained in the LN draining the site of a tumor may provide a valuable source of effector cells which can be used in the immunotherapeutic treatment of cancer.
给小鼠注射活的同基因肿瘤细胞后,其引流淋巴结(LN)中含有淋巴细胞群体,这些淋巴细胞群体在体外培养期间能够产生功能性细胞毒性T淋巴细胞(CTL),无需用辐照肿瘤细胞进行二次刺激或添加外源性细胞因子。按照此方案产生的低至2.5×10⁶个肿瘤反应性效应细胞经静脉注射,可有效消除远端皮肤部位肿瘤细胞的攻击,而注射培养的对照淋巴细胞则无法有效排斥肿瘤攻击。发现用活的同基因肿瘤细胞免疫的C57BL10小鼠引流淋巴结产生的抗肿瘤CTL在体外和体内均对用于免疫的肿瘤具有特异性。对负责消除肿瘤的细胞(包括体外和体内)进行表型分析,结果显示抗肿瘤效应细胞为CD4⁻CD8⁺唾液酸缺乏GM1⁺NK1.1⁻。最后,在短时间体外培养期间产生的抗肿瘤CTL能够以全身方式有效排斥体内预先存在的肿瘤。这些数据表明,从肿瘤部位引流淋巴结中所含淋巴细胞产生肿瘤反应性CTL可能提供一种有价值的效应细胞来源,可用于癌症的免疫治疗。